US Stock MarketDetailed Quotes

CATX Perspective Therapeutics

Watchlist
  • 3.4800
  • +0.0100+0.29%
Close Dec 13 16:00 ET
  • 3.6000
  • +0.1200+3.45%
Post 20:01 ET
235.20MMarket Cap-2.34P/E (TTM)

Perspective Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Perspective Therapeutics Q3 2024 Earnings Date

Currency：USDNov 12, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
237.91K
0
-237.91K
Miss Est.
-87.54%
--
-100.00%
EPS
-0.19
-0.21
-0.02
Miss Est.
+52.14%
+43.24%
-9.72%
Analyst Rating
Strong Buy

Nov 30, 2024

Perspective Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 151.330K--
--2024/Q4-- / 257.760K--
Nov 12, 20242024/Q3369.000K / 237.910K--
Aug 12, 20242024/Q2526.000K / 135.630K--
May 15, 20242024/Q1325.000K / 68.800K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 151.330K--
--2024/Q4-- / 257.760K--
Nov 12, 20242024/Q3369.000K / 237.910K--
Aug 12, 20242024/Q2526.000K / 135.630K--
May 15, 20242024/Q1325.000K / 68.800K--

Unlock Free Earnings Estimates

Perspective Therapeutics Earnings Reports

  • Perspective Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 12 16:18 ET

  • Perspective Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 13 16:10 ET

  • Perspective Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 15 22:44 ET

  • Perspective Therapeutics | 10-K: FY2023 Annual Report

    Mar 28 08:39 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      88.89%

    • Hold

      11.11%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data